| abstract |
The invention relates to compositions containing amylin or an amylin agonist and a glucagon compound, especially peptide compounds, and for regulating glucose production in mammals. These compositions are used to treat hypoglycemia, in particular acute hypoglycemic conditions caused for example by an overdose of insulin and by the misuse of oral hypoglycemic agents. |